Key Updates in GI Oncology From ESMO 2026
Paediatric Oncology Content at London Global Cancer Week (LGCW) 2026
Grace Helbig Brain Tumors: Surgery After Breast Cancer
Antonella Cardone on Why “Time Is of Essence” in Cancer Care - CancerWorld
Amol Akhade at COGC 2026: When Precision Oncology Becomes "Precision Confusion"
ESMO 2026: The Key Pembrolizumab Trials to Know
Marina Konopleva at LeukO 2026: Beyond Venetoclax - The Next Breakthroughs in AML Treatment
AI-Generated Control Arms in Hematology Trials: Promise, Challenges, and Clinical Validity
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
